大葉大學圖書館 |

登入

回首頁

Resistance to tyrosine kinase inhibi...

Focosi, Daniele.

Resistance to tyrosine kinase inhibitors[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	615.798
書名/作者:	Resistance to tyrosine kinase inhibitors/ edited by Daniele Focosi.
其他作者:	Focosi, Daniele.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	xiii, 188 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Protein-tyrosine kinase - Inhibitors.
標題:	Drug resistance.
標題:	Biomedicine.
標題:	Cancer Research.
ISBN:	9783319460918
ISBN:	9783319460901
內容註:	Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells -- Resistance to Tyrosine Kinase Inhibitors in different types of solid cancer -- The Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: An Overview -- Resistance to FLT3 Inhibitors -- Resistance to ALK inhibitors -- Resistance to Angiokinase Inhibitors -- Indications for Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors.
摘要、提要註:	The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.
電子資源:	http://dx.doi.org/10.1007/978-3-319-46091-8

Resistance to tyrosine kinase inhibitors[electronic resource] /
Resistance to tyrosine kinase inhibitors[electronic resource] /edited by Daniele Focosi. - Cham :Springer International Publishing :2016. - xiii, 188 p. :ill., digital ;24 cm. - Resistance to targeted anti-cancer therapeutics,v.102196-5501 ;. - Resistance to targeted anti-cancer therapeutics ;v.4..

Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells -- Resistance to Tyrosine Kinase Inhibitors in different types of solid cancer -- The Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: An Overview -- Resistance to FLT3 Inhibitors -- Resistance to ALK inhibitors -- Resistance to Angiokinase Inhibitors -- Indications for Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors.

The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.

ISBN: 9783319460918

Standard No.: 10.1007/978-3-319-46091-8doiSubjects--Topical Terms:

687095
Protein-tyrosine kinase
--Inhibitors.

LC Class. No.: RC271.P76

Dewey Class. No.: 615.798

Resistance to tyrosine kinase inhibitors[electronic resource] /
LDR:01900nam a2200325 a 4500 001 476382
003 DE-He213
005 20161107143620.0
006 m d
007 cr nn 008maaau
008 181208s2016 gw s 0 eng d
020 $a 9783319460918 $q (electronic bk.)
020 $a 9783319460901 $q (paper)
024 7 $a 10.1007/978-3-319-46091-8 $2 doi
035 $a 978-3-319-46091-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.P76
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 615.798 $2 23
090 $a RC271.P76 $b R433 2016
245 0 0 $a Resistance to tyrosine kinase inhibitors $h [electronic resource] / $c edited by Daniele Focosi.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xiii, 188 p. : $b ill., digital ; $c 24 cm.
490 1 $a Resistance to targeted anti-cancer therapeutics, $x 2196-5501 ; $v v.10
505 0 $a Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells -- Resistance to Tyrosine Kinase Inhibitors in different types of solid cancer -- The Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: An Overview -- Resistance to FLT3 Inhibitors -- Resistance to ALK inhibitors -- Resistance to Angiokinase Inhibitors -- Indications for Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors.
520 $a The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.
650 0 $a Protein-tyrosine kinase $x Inhibitors. $3 687095
650 0 $a Drug resistance. $3 488801
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Cancer Research. $3 463530
700 1 $a Focosi, Daniele. $3 687094
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Resistance to targeted anti-cancer therapeutics ; $v v.4. $3 603047
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-46091-8
950 $a Biomedical and Life Sciences (Springer-11642)

筆 0 讀者評論

多媒體

多媒體檔案
http://dx.doi.org/10.1007/978-3-319-46091-8

評論

新增評論分享你的心得

Export

取書館別